A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial.

Kazuhiro NishikawaAkira TsuburayaTakaki YoshikawaMasazumi TakahashiKazuaki TanabeKensei YamaguchiShigefumi YoshinoTsutomu NamikawaToru AoyamaYasushi RinoJunji KawadaAkihito TsujiKoichi TairaYutaka KimuraYasuhiro KoderaYoshinori HirashimaHiroshi YabusakiNaoki HirabayashiKazumasa FujitaniYumi MiyashitaSatoshi MoritaJunichi Sakamoto

Published in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2018)

NCT01412294.

Keyphrases

phase iii
open label
phase ii
clinical trial
neoadjuvant chemotherapy
study protocol
placebo controlled
phase ii study
locally advanced
free survival
double blind
metastatic breast cancer
metastatic colorectal cancer
randomized controlled trial